WPC
LFCR icon

White Pine Capital’s Lifecore Biomedical LFCR Stock Holding History

White Pine Capital’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-51,472
Closed -$558K – 239
2020
Q4 		$558K Sell
51,472
-103,142
-67% -$1.07M 0.2% 135
2020
Q3 		$1.5M Buy
154,614
+26,615
+21% +$253K 0.61% 43
2020
Q2 		$1.02M Sell
127,999
-551
-0.4% -$5.68K 0.43% 65
2020
Q1 		$1.12M Buy
128,550
+975
+0.8% +$10.1K 0.57% 47
2019
Q4 		$1.44M Sell
127,575
-42,350
-25% -$451K 0.56% 50
2019
Q3 		$1.85M Buy
+169,925
New +$1.85M 0.69% 37

Other funds holding LFCR

LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

White Pine Capital's LFCR Position: Q1 2021 in Review

White Pine Capital sold out of Lifecore Biomedical (LFCR) in Q1 2021, closing a stake of 51,472 shares — an estimated $558K sold.

White Pine Capital first reported a position in LFCR in Q3 2019 and held it in 6 quarters. The position peaked at $1.85M in Q3 2019. 93 funds tracked by Wall St. Rank hold LFCR as of Q1 2021.

  • White Pine Capital reported no remaining Lifecore Biomedical position as of Q1 2021 after selling out during the quarter.
  • White Pine Capital sold 51,472 Lifecore Biomedical shares in Q1 2021, an estimated $558K.
  • White Pine Capital first reported a position in Lifecore Biomedical in Q3 2019 and held it in 6 quarters.
  • White Pine Capital's Lifecore Biomedical position peaked at $1.85M in Q3 2019.
  • 93 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2021.

Based on White Pine Capital's 13F filing for Q1 2021, filed 12 May 2021.